Schedule 13D ownership disclosure

Phathom Pharmaceuticals Inc

Security class unavailable · CUSIP: 71722W107

Event date: 2019-10-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
25.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-285680
Form type
SC 13D
Filer
Frazier Life Sciences IX, L.P.
CIK
CIK 1720320
Filed
Nov 06, 2019
Reporting period
Oct 29, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub